A detailed history of State Of Wyoming transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, State Of Wyoming holds 3,802 shares of CDMO stock, worth $45,357. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,802
Previous 3,600 5.61%
Holding current value
$45,357
Previous $25,000 72.0%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $1,353 - $2,514
202 Added 5.61%
3,802 $43,000
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $1,692 - $2,477
267 Added 8.01%
3,600 $25,000
Q1 2024

May 13, 2024

SELL
$5.86 - $8.79 $14,087 - $21,131
-2,404 Reduced 41.9%
3,333 $22,000
Q4 2023

Feb 14, 2024

SELL
$4.64 - $9.56 $2,672 - $5,506
-576 Reduced 9.12%
5,737 $37,000
Q3 2023

Nov 14, 2023

BUY
$9.4 - $14.04 $23,020 - $34,383
2,449 Added 63.38%
6,313 $59,000
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $12,947 - $20,909
999 Added 34.87%
3,864 $53,000
Q1 2023

May 12, 2023

BUY
$13.48 - $18.79 $1,873 - $2,611
139 Added 5.1%
2,865 $53,000
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $30,881 - $45,894
-2,449 Reduced 47.32%
2,726 $37,000
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $41,222 - $54,748
2,689 Added 108.17%
5,175 $99,000
Q2 2022

Aug 15, 2022

SELL
$11.63 - $21.55 $57,661 - $106,844
-4,958 Reduced 66.6%
2,486 $38,000
Q1 2022

May 13, 2022

BUY
$16.63 - $27.73 $6,685 - $11,147
402 Added 5.71%
7,444 $152,000
Q4 2021

Feb 11, 2022

BUY
$20.7 - $34.18 $4,533 - $7,485
219 Added 3.21%
7,042 $205,000
Q3 2021

Feb 11, 2022

SELL
$19.05 - $28.32 $28,060 - $41,715
-1,473 Reduced 17.76%
6,823 $147,000
Q2 2021

Feb 11, 2022

BUY
$18.93 - $25.65 $157,043 - $212,792
8,296 New
8,296 $213,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $742M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.